IBRUTINIB RESISTANCE

Clinical trials for IBRUTINIB RESISTANCE explained in plain language.

Never miss a new study

Get alerted when new IBRUTINIB RESISTANCE trials appear

Sign up with your email to follow new studies for IBRUTINIB RESISTANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to beat Leukemia's resistance to treatment

Disease control Ongoing

This study is testing whether adding a drug called venetoclax to an existing treatment (ibrutinib) can help patients with chronic lymphocytic leukemia (CLL) whose cancer has become resistant. The goal is to eliminate the genetic changes that cause resistance and better control th…

Matched conditions: IBRUTINIB RESISTANCE

Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

IBRUTINIB RESISTANCE

Get alerted when new IBRUTINIB RESISTANCE trials appear

New drug combo aims to beat Leukemia's resistance to treatment